Seqirus Uk competitive analysis

Explore patent oppositions filed by Seqirus Uk against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Method For Producing Rna CompositionsCUREVACOct 1, 2024
Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNADec 1, 2022
Nucleic Acid VaccinesMODERNASep 21, 2022
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNASep 1, 2022
Novel MethodGLAXOSMITHKLINE BIOLOGICALS SASep 30, 2016

Explore Seqirus Uk's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Jul 15, 2020Improved Methods For Preparing Squalene1
Aug 21, 2019Vaccination With Multiple Clades Of H5 Influenza A Virus2
Feb 6, 2019Manufacture Of An Oil-In-Water Emulsion Comprising Squalene2
Sep 28, 2016Influenza Vaccines With Reduced Amounts Of Squalene1
Oct 7, 2015Hydrophilic Filtration During Manufacture Of Vaccine Adjuvants2
Aug 12, 2015Influenza Vaccine Regimens For Pandemic-Associated Strains1
May 6, 2015Influenza Vaccination1
Dec 10, 2014Soluble Needle Arrays For Delivery Of Influenza Vaccines2

Latest PTAB cases involving Seqirus Uk

Discover the latest PTAB cases involving Seqirus Uk, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Seqirus Uk with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
SEQIRUS UK512 - -
CUREVAC MANUFACTURING - 28 - -
GLAXOSMITHKLINE BIOLOGICALS SA2910429
MODERNA57912